P-12, r. 6 - Regulation respecting the medications that a podiatrist may use in the practice of his profession or administer or prescribe to his patients

Full text
SCHEDULE I
NOTE : Medications without specification are intended for topical application.

________________________________________________________________

Substances Specification
________________________________________________________________

Acetaminophen Pharmaceutical forms intended
for oral and rectal
administration

Acetic, glacial acid

Acetylsalicylic, Pharmaceutical forms intended
for oral administration

Aluminium and its salts

Almond, sweet oil

Amino acids

Amcinonide Quantity limited for 30 days

Anthralin (dithranol)

Silver nitrate

Silver sulfadiazine

Colloidal oatmeal

Bacitracin and its salts

Beclomethasone and its salts

Benzalkonium

Benzocaine

Betamethasone benzoate

Betamethasone Quantity limited for 30 days
dipropionate

Betamethasone valerate

Bupivacaine and Pharmaceutical forms intended
its salts for administration by injection
for local use only

Calcipotriol

Calcium acetate

Camphor

Cantharin

Capsaicin

Cetrimide

Cetirizine Pharmaceutical form intended
hydrochloride for oral administration

Chlorhexidine and its salts

Chlorphenesin

Chlorprocaine Pharmaceutical form intended
hydrochloride for administration by injection
for local use only

Ciclopirox olamine

Cinchocaine

Clioquinol
(iodochlorhydroxyquin)

Clobetasol Quantity limited for 30 days
proprionate

Clobetasone butyrate

Clotrimazole

Collagenase

Dakin’s solution

Desonide

Desoximetasone Quantity limited for 30 days

Deoxyribonuclease

Dichloracetic acid

Diflucortolone Quantity limited for 30 days
valerate

Diphenhydramine Pharmaceutical forms intended
for oral and topical
administration

Econazole nitrate

Epinephrine Pharmaceutical forms for the
(adrenaline) emergency treatment of
anaphylactic reactions in
the form of self-injector or
vial

Pharmaceutical form associated
with local anaesthetics

Erythromycin

Ethyl chloride

Fibrinolysin

Flumetasone pivalate

Fluocinolone Quantity limited for 30 days
acetonide

Fluocinode Quantity limited for 30 days

Formalin

Framycetin sulfate

Fusidic acid

Gentamicin sulfate

Gentian, violet

Mineral and vegetal tar

Gramicidin

Halcinodide Quantity limited for 30 days

Hexachlorophene

Mineral oil

Hydrocortisone and its salts

Hydroxyzine Pharmaceutical form intended
hydrochloride for oral administration

Povidone iodine

Iodine tincture

Isopropyl myristate

Ketoconazole

Lactic acid

Lanolin

Lidocaine and Pharmaceutical forms intended
its salts for topical application and
administration by injection
for local use only

Loratadine Pharmaceutical form intended
for oral administration

Lorazepam Pharmaceutical form intended
for oral and sublingual
administration in anticipation
of surgical procedures,
containing 0.5 mg or 1 mg
of Lorazepam per tablet

Quantity limited to 4 tablets

Mafenide and its salts

Menthol

Mepivacaine Pharmaceutical form intended
for administration by injection
for local use only

Methylpolysiloxanes

Methylprednisolone acetate

Miconazole nitrate

Mometasone furorate

Mupirocin

Neomycin sulfate

Nystatin

Oxiconazole

Phenol

Podophyllin

Polymyxin B sulfate

Pramoxine

Prilocaine Pharmaceutical forms intended
for topical application and
administration by injection
for local use only

Procaine Pharmaceutical form intended
for administration by injection
for local use only

Resorcinol and its salts

Diethylamine salicylate

Magnesium salicylate

Methyl salicylate

Triethanolamine salicylate

Salicylic acid

Synthetic sebum

Silicone

Sodium thiosulfate

Sulphur, colloidal,
precipitate or sublimate

Tazarotene

Terbinafine

Tetracaine and Pharmaceutical forms intended
its salts for topical application and
administration by injection
for local use only

Tioconazole

Tolnaftate

Triamcinolone Quantity limited for 30 days
acetonide

Trichloroacetic acid

Urea Pharmaceutical form intended
for topical application, with
a concentration of 30% or less

White petroleum jelly

Zinc oxide
O.C. 1057-91, Sch. I; O.C. 142-2003, s. 3; O.C. 522-2005, s. 1.